<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00273754</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-03-108</org_study_id>
    <nct_id>NCT00273754</nct_id>
  </id_info>
  <brief_title>The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).</brief_title>
  <acronym>OSA</acronym>
  <official_title>A Pilot Study to Evaluate if Caffeine Helps Children With Obstructive Sleep Apnea Recover Faster From Anesthesia, and With Less Complications After General Anesthesia for Tonsillectomy and Adenoidectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study using caffeine in children who have an obstructive sleep apnea
      (OSA). OSA means children who stop breathing during their sleep due to obstruction in their
      airway. The purpose of this study is to determine whether caffeine when given in the vein,
      will wake children up faster and decrease post-anesthesia airway obstruction, as well as the
      safety and if the drug agrees with the child compared to a placebo (an inactive or dummy
      agent).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with OSA are reported to have a higher rate of severe respiratory complications
      associated with upper airway obstruction during anesthesia and sedation or immediately after
      anesthesia. Children with OSA (especially those under three years of age, those with severe
      OSA, cerebral palsy or craniofacial anomalies) are at increased risks for post-operative
      complications, and require careful monitoring post-operatively.

      Although the etiology of obstructive sleep apnea is mainly obstruction due to anatomical and
      neuromuscular abnormalities, we believe that a central element may contribute to OSA.

      The aim of this study is to evaluate whether administration of caffeine to children with OSA,
      scheduled for elective T &amp; A under general anesthesia contributes to a faster recovery, less
      post-operative complications, and a shorter stay in the PACU, DSU and the hospital.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Children Who Developed Postextubation Adverse Respiratory Events Compared to Placebo.</measure>
    <time_frame>Time post extubation in OR and PACU until the patient was discharged from the PACU to go home or to a hospital room.</time_frame>
    <description>The number of children having adverse post-extubation respiratory events, including laryngospasm, upper airway obstruction, apnea, desaturation (defined as decrease in oxygen saturation &lt;95% while breathing oxygen via mask for any length of time) and need for reintubation, both in the Operating Room and in the PACU was recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurence of Post Extubatory Respiratory Adverse Events.</measure>
    <time_frame>Time post extubation in OR and PACU until the patient was discharged from the PACU to go home or to a hospital room.</time_frame>
    <description>The overall occurance of adverse post-extubation respiratory events, including laryngospasm, upper airway obstruction, apnea, desaturation (defined as decrease in oxygen saturation &lt;95% while breathing oxygen via mask for any length of time) and need for reintubation, both in the OR and in the PACU was noted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation Time.</measure>
    <time_frame>Duration from anesthesia end until extubation time.</time_frame>
    <description>Time from end of anesthesia until extubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awakening Time</measure>
    <time_frame>Awakening time from end of anesthesia until the child reached a score of 6 on the Steward recovery score.</time_frame>
    <description>A child with a Steward Recovery Scale score of 6 is defined as awake, coughing/crying, and has purposeful movements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Anesthesia Care Unit (PACU) Duration</measure>
    <time_frame>Time spent in PACU following surgical procedure prior to discharge home or hospital admission.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Discharge Time</measure>
    <time_frame>Total time from end anesthesia to discharge home</time_frame>
    <description>Children were discharged from the hospital when they reached the hospital discharge criteria: they were awake, had stable vital signs, were breathing adequately, had O2 saturation &gt;95% while breathing room air, were able to swallow fluids, had no or minimal pain, and were able to ambulate without excessive nausea, vomiting, or dizziness.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Tonsillectomy</condition>
  <condition>Adenoidectomy</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Caffeine benzoate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>Children in group one will receive caffeine benzoate 20 mg/kg i.v., which is equal to a 10 mg/kg caffeine base.</description>
    <arm_group_label>Caffeine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Children in group two will receive an amount of normal saline equal to Caffeine</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children between 2.5-18 years old

          -  Diagnosed with obstructive sleep apnea

          -  Undergoing elective tonsillectomy and adenoidectomy

        Exclusion Criteria:

          -  Age below 2.5 or above 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samia N. Khalil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas, Health Science Center at Houston, Children's Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2006</study_first_submitted>
  <study_first_submitted_qc>January 4, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2006</study_first_posted>
  <results_first_submitted>June 5, 2009</results_first_submitted>
  <results_first_submitted_qc>October 14, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 10, 2010</results_first_posted>
  <last_update_submitted>May 12, 2016</last_update_submitted>
  <last_update_submitted_qc>May 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Samia Khalil</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea (OSA)</keyword>
  <keyword>Tonsillectomy and Adenoidectomy (T&amp;A)</keyword>
  <keyword>Postoperative Complications</keyword>
  <keyword>Recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Normal Saline</description>
        </group>
        <group group_id="P2">
          <title>Caffeine</title>
          <description>Caffeine benzoate</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Normal Saline</description>
        </group>
        <group group_id="B2">
          <title>Caffeine</title>
          <description>Caffeine benzoate</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.3" spread="2.9"/>
                    <measurement group_id="B2" value="5.3" spread="2.2"/>
                    <measurement group_id="B3" value="5.3" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Children Who Developed Postextubation Adverse Respiratory Events Compared to Placebo.</title>
        <description>The number of children having adverse post-extubation respiratory events, including laryngospasm, upper airway obstruction, apnea, desaturation (defined as decrease in oxygen saturation &lt;95% while breathing oxygen via mask for any length of time) and need for reintubation, both in the Operating Room and in the PACU was recorded.</description>
        <time_frame>Time post extubation in OR and PACU until the patient was discharged from the PACU to go home or to a hospital room.</time_frame>
        <population>The analysis was per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Caffeine</title>
            <description>Caffeine benzoate</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Children Who Developed Postextubation Adverse Respiratory Events Compared to Placebo.</title>
          <description>The number of children having adverse post-extubation respiratory events, including laryngospasm, upper airway obstruction, apnea, desaturation (defined as decrease in oxygen saturation &lt;95% while breathing oxygen via mask for any length of time) and need for reintubation, both in the Operating Room and in the PACU was recorded.</description>
          <population>The analysis was per protocol.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Occurence of Post Extubatory Respiratory Adverse Events.</title>
        <description>The overall occurance of adverse post-extubation respiratory events, including laryngospasm, upper airway obstruction, apnea, desaturation (defined as decrease in oxygen saturation &lt;95% while breathing oxygen via mask for any length of time) and need for reintubation, both in the OR and in the PACU was noted.</description>
        <time_frame>Time post extubation in OR and PACU until the patient was discharged from the PACU to go home or to a hospital room.</time_frame>
        <population>Per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Caffeine</title>
            <description>Caffeine benzoate</description>
          </group>
        </group_list>
        <measure>
          <title>Occurence of Post Extubatory Respiratory Adverse Events.</title>
          <description>The overall occurance of adverse post-extubation respiratory events, including laryngospasm, upper airway obstruction, apnea, desaturation (defined as decrease in oxygen saturation &lt;95% while breathing oxygen via mask for any length of time) and need for reintubation, both in the OR and in the PACU was noted.</description>
          <population>Per protocol</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Extubation Time.</title>
        <description>Time from end of anesthesia until extubation.</description>
        <time_frame>Duration from anesthesia end until extubation time.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Caffeine</title>
            <description>Caffeine benzoate</description>
          </group>
        </group_list>
        <measure>
          <title>Extubation Time.</title>
          <description>Time from end of anesthesia until extubation.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" spread="9.4"/>
                    <measurement group_id="O2" value="8.6" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Awakening Time</title>
        <description>A child with a Steward Recovery Scale score of 6 is defined as awake, coughing/crying, and has purposeful movements.</description>
        <time_frame>Awakening time from end of anesthesia until the child reached a score of 6 on the Steward recovery score.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Caffeine</title>
            <description>Caffeine benzoate</description>
          </group>
        </group_list>
        <measure>
          <title>Awakening Time</title>
          <description>A child with a Steward Recovery Scale score of 6 is defined as awake, coughing/crying, and has purposeful movements.</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.6" spread="16.0"/>
                    <measurement group_id="O2" value="26.1" spread="28.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Anesthesia Care Unit (PACU) Duration</title>
        <time_frame>Time spent in PACU following surgical procedure prior to discharge home or hospital admission.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Caffeine</title>
            <description>Caffeine benzoate</description>
          </group>
        </group_list>
        <measure>
          <title>Post Anesthesia Care Unit (PACU) Duration</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.4" spread="43.7"/>
                    <measurement group_id="O2" value="84.8" spread="44.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Discharge Time</title>
        <description>Children were discharged from the hospital when they reached the hospital discharge criteria: they were awake, had stable vital signs, were breathing adequately, had O2 saturation &gt;95% while breathing room air, were able to swallow fluids, had no or minimal pain, and were able to ambulate without excessive nausea, vomiting, or dizziness.</description>
        <time_frame>Total time from end anesthesia to discharge home</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Normal Saline</description>
          </group>
          <group group_id="O2">
            <title>Caffeine</title>
            <description>Caffeine benzoate</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Discharge Time</title>
          <description>Children were discharged from the hospital when they reached the hospital discharge criteria: they were awake, had stable vital signs, were breathing adequately, had O2 saturation &gt;95% while breathing room air, were able to swallow fluids, had no or minimal pain, and were able to ambulate without excessive nausea, vomiting, or dizziness.</description>
          <units>Minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.0" spread="54.5"/>
                    <measurement group_id="O2" value="98.2" spread="55.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Normal Saline</description>
        </group>
        <group group_id="E2">
          <title>Caffeine</title>
          <description>Caffeine benzoate</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Samia Khalil, M.D./ Professor</name_or_title>
      <organization>University of Texas Medical School/ Houston</organization>
      <phone>713-500-6242</phone>
      <email>Samia.N.Khalil@uth.tmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

